Close Menu

NEW YORK — C2i Genomics said on Thursday that it has acquired CLIA-certified sequencing lab QNA Dx in an effort to speed the commercialization of its MRDetect cancer monitoring platform.

Financial terms of the transaction were not disclosed. C2i said that it will retain all of QNA's employees and continue its lab operations.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.